Beta Drugs bulk deals, insider trading and stake changes
NSE: BETAPharmaceuticals & BiotechnologySmall Cap
Beta Drugs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 2017 · Issue price ₹85
Last close ₹1,934.20down ₹43.70 (2.21%)
Share price at the NSE close on 27 Oct 2026. Previous close ₹1,977.90.
27 Oct: open ₹1,977.90, high ₹2,028.00, low ₹1,862.10
52-week range of traded prices to 27 Oct 2026
₹990.10Low, 25 Feb 2026₹2,807.90High, 12 Aug 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 27 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,151 Cr1,305th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 39.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.91
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 16.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 60,45338.6% delivered
Beta Drugs' insiders have 26 trade disclosures on record, the latest on 30 Sep 2026. Over the 12 months to 27 Oct 2026 its promoter group made 1 sale on the market, a net sale of 1,85,115 shares.
Promoter and insider buying and selling
Trades made since 28 Oct 2025.Beta Drugs promoter holding
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group0 purchases, 1 saleNo purchase₹31 CrNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.−₹31 Cr
- Others: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Beta Drugs insider trading
Aug 2026
- INTI CAPITAL VCC-INTI CAPITAL I₹50 Cr2,11,691 sharesBought · Designated Person · 4 Aug 2026 · disclosed 30 Sep
- HEALTHQUAD TRUST II₹107 Cr4,53,623 sharesBought · Designated Person · 4 Aug 2026 · disclosed 30 Sep
Nov 2025
- Neeraj Batra₹31 Cr1,85,115 sharesSold · Promoters · 13 Nov 2025 · stake 65.96% before, 64.13% after
Mar 2025
- Rahul Batra1,982sharesReceived · Promoters · 27 Mar 2025 · disclosed 29 Mar · Bonus · held 39,650 before, holds 41,632 after, stake 0.41% after
- Heena Batra29sharesReceived · Promoters · 27 Mar 2025 · disclosed 29 Mar · Bonus · stake 0.01% before, 0.01% after
- Aditi Batra29sharesReceived · Promoters · 27 Mar 2025 · disclosed 29 Mar · Bonus · stake 0.01% before, 0.01% after
- Neeraj Batra3,17,083sharesReceived · Promoters · 27 Mar 2025 · disclosed 29 Mar · Bonus · held 63,41,663 before, holds 66,58,746 after, stake 65.96% after
- Varun Batra1,661sharesReceived · Promoters · 27 Mar 2025 · disclosed 29 Mar · Bonus · held 33,230 before, holds 34,891 after, stake 0.35% after
Jan 2023
- Rahul Batra₹0.16 Cr2,400 sharesReceived · Promoters · 20 Jan 2023 · Others · stake 0.39% before, 0.41% after
Aug 2022
- NEERAJ BATRA₹15 Cr1,83,648 sharesBought · Promoter · 24 Aug 2022 · disclosed 22 Sep
- VIJAY KUMAR BATRA₹15 Cr1,83,648 sharesSold or invoked · Promoter · 24 Aug 2022 · disclosed 22 Sep
Jul 2022
- VIJAY KUMAR BATRA₹435 Cr61,31,180 sharesSold or invoked · Promoter · 1 Jul 2022 · disclosed 31 Aug
- NEERAJ BATRA₹435 Cr61,31,180 sharesBought · Promoter · 1 Jul 2022 · disclosed 31 Aug
Nov 2021
1 entry
- Rahul Batra₹0.17 Cr2,800 sharesBought · Promoters · 4 Nov 2021 · disclosed 8 Nov · stake 0.35% before, 0.38% after
Oct 2021
1 entry
- RAHUL BATRA₹0.17 Cr2,800 sharesBought · Designated Person · 8 Oct 2021 · disclosed 9 Nov
Nov 2020
1 entry
- Vijay Kumar Batra₹0.08 Cr6,400 sharesBought · Promoters · 14 Nov 2020 · disclosed 16 Nov · held 63,07,628 before, holds 63,14,028 after
Sep 2020
1 entry
- Vijay Kumar Batra₹0.43 Cr50,400 sharesBought · Promoters · 1 Sep 2020 · held 62,57,228 before, holds 63,07,628 after
Mar 2020
2 entries
- Vijay Kumar Batra₹0.09 Cr20,000 sharesBought · Promoters · 16 Mar 2020 · disclosed 18 Mar · held 62,37,228 before, holds 62,57,228 after
- Vijay Kumar Batra₹0.21 Cr43,200 sharesBought · Promoters · 11 Mar 2020 · disclosed 13 Mar · held 61,94,028 before, holds 62,37,228 after
Oct 2019
1 entry
- Vijay Kumar Batra₹0.10 Cr10,400 sharesBought · Promoters · 27 Oct 2019 · disclosed 29 Oct · held 61,83,628 before, holds 61,94,028 after
Jul 2019
5 entries
- Vijay Kumar Batra₹0.25 Cr26,400 sharesBought · Promoter Group · 9 Jul 2019 · disclosed 11 Jul · held 61,57,228 before, holds 61,83,628 after
- Neeraj Batra₹0.21 Cr23,885 sharesReceived · Promoters · 1 Jul 2019 · disclosed 2 Jul · Preferential Offer · held 2,950 before, holds 26,835 after
- Varun Batra₹0.17 Cr18,480 sharesReceived · Promoters · 1 Jul 2019 · disclosed 2 Jul · Preferential Offer · held 14,750 before, holds 33,230 after
- Rahul Batra₹0.18 Cr19,700 sharesReceived · Promoters · 1 Jul 2019 · disclosed 2 Jul · Preferential Offer · held 14,750 before, holds 34,450 after
- Vijay Kumar Batra₹1.65 Cr1,83,648 sharesReceived · Promoters · 1 Jul 2019 · disclosed 2 Jul · Preferential Offer · held 59,73,580 before, holds 61,57,228 after
Nov 2018
1 entry
- Vijay Kumar Batra48,800sharesBought · Promoters · 29 Nov 2018 · disclosed 1 Dec · held 59,24,780 before, holds 59,73,580 after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Beta Drugs stake sales and purchases
All 17 disclosures on record.
Nov 2025
- SoldNeeraj Batra, Rahul Batra, Varun Batra, Heena Batra & Aditi Batra · promoter1.83% of the company1,85,115 sharesholds 64.90% after13 Nov 2025 · filed under the 2% rule · Open Market
Mar 2025
- AcquiredNeeraj Batra, Rahul Batra, Varun Batra, Heena Batra & Aditi Batra · promoter5.00% of the company3,20,784 sharesholds 66.73% after27 Mar 2025 · filed under the 2% rule
Aug 2021
- AcquiredAshish R Kacholia2.03% of the company1,95,200 sharesholds 12.12% after30 Aug 2021 · filed under the 2% rule · Open Market
Nov 2020
- AcquiredVijay Kumar Batra · promoter0.06% of the company6,400 sharesholds 65.67% after14 Nov 2020 · filed under the 2% rule · Open Market
Sep 2020
- AcquiredVijay Kumar Batra · promoter0.52% of the company50,400 sharesholds 65.61% after1 Sep 2020 · filed under the 2% rule · Open Market
Mar 2020
- AcquiredVijay Kumar Batra · promoter0.20% of the company20,000 sharesholds 65.08% after18 Mar 2020 · filed under the 2% rule · Open Market
- AcquiredVijay Kumar Batra · promoter0.45% of the company43,200 sharesholds 64.88% after13 Mar 2020 · filed under the 2% rule · Open Market
Jan 2020
1 entry
- AcquiredAshish R. Kacholia2.71% of the company2,60,800 sharesholds 10.73% after31 Jan 2020 · filed under the 2% rule · Open Market
Oct 2019
1 entry
- AcquiredVijay Kumar batra · promoter0.11% of the company10,400 sharesholds 64.43% after27 Oct 2019 · filed under the 2% rule · Open Market
Jul 2019
5 entries
- AcquiredVijay Kumar Batra · promoter0.27% of the company26,400 sharesholds 64.32% after9 Jul 2019 · filed under the 2% rule · Open Market
- AcquiredNeeraj Batra · promoter0.25% of the company23,885 sharesholds 0.28% after1 Jul 2019 · filed under the 2% rule
- AcquiredRahul Batra · promoter0.20% of the company19,700 sharesholds 0.36% after1 Jul 2019 · filed under the 2% rule
- AcquiredVijay Kumar Batra · promoter1.91% of the company1,83,648 sharesholds 64.05% after1 Jul 2019 · filed under the 2% rule
- AcquiredVarun Batra · promoter0.19% of the company18,480 sharesholds 0.34% after1 Jul 2019 · filed under the 2% rule
May 2019
2 entries
- AcquiredSuryavanshi Commotrade Pvt Ltd6.94% of the company6,45,244 sharesholds 8.02% after1 May 2019 · filed under the 5% rule · Preferential Allotment
- AcquiredSuryavanshi Commotrade Pvt Ltd6.94% of the company6,45,244 sharesholds 6.94% after1 May 2019 · filed under the 2% rule · Preferential Allotment
Nov 2018
1 entry
- AcquiredVijay Kumar Batra · promoter0.56% of the company48,800 sharesholds 59,73,580 shares after29 Nov 2018 · filed under the 2% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Beta Drugs bulk deals
Last 12 months, since 28 Oct 2025: 2 bulk deals, ₹26 Cr bought and ₹31 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 13 Nov 20252 firms · ₹26 Cr bought · ₹31 Cr soldNet sold ₹4.92 Cr
- SoldNEERAJ BATRASold 1,85,115 at ₹1,686.001.83% of the company₹31 Cr
- BoughtAIRAVAT CAPITAL TRUST IIBought 1,55,925 at ₹1,686.001.54% of the company₹26 Cr
Tuesday 1 Sep 20201 firm · ₹0.43 Cr bought · ₹0 soldNet bought ₹0.43 Cr
- BoughtBATRA VIJAY KUMARBought 50,400 at ₹84.95₹0.43 Cr
Friday 24 Jul 20202 firms · ₹0.84 Cr bought · ₹1.03 Cr soldNet sold ₹0.19 Cr
- SoldADESH VENTURES LLPSold 1,08,000 at ₹95.52₹1.03 Cr
- BoughtONKAR SINGHBought 87,200 at ₹96.03₹0.84 Cr
Thursday 29 Nov 20181 firm · ₹0.36 Cr bought · ₹0 soldNet bought ₹0.36 Cr
- BoughtBATRA VIJAY KUMARBought 48,800 at ₹73.25₹0.36 Cr
Monday 29 Oct 20182 firms · ₹0.35 Cr bought · ₹0.36 Cr soldNet sold ₹0.01 Cr
- SoldVALUEWORTH CAPITAL MANAGEMENT PVT LTDSold 52,000 at ₹70.06₹0.36 Cr
- BoughtSACHIN KASERABought 50,400 at ₹70.00₹0.35 Cr
Monday 23 Jul 20181 firm · ₹0 bought · ₹0.46 Cr soldNet sold ₹0.46 Cr
- SoldVORA FINANCIAL SERVICES PRIVATELIMITEDSold 51,200 at ₹90.14₹0.46 Cr
Tuesday 17 Oct 20172 firms · ₹0 bought · ₹0.97 Cr soldNet sold ₹0.97 Cr
- SoldV N SHAHSold 51,200 at ₹95.71₹0.49 Cr
- SoldSHATRUNJAY INVESTMENTSSold 49,600 at ₹96.27₹0.48 Cr
Friday 13 Oct 20174 firms · ₹1.25 Cr bought · ₹1.50 Cr soldNet sold ₹0.25 Cr
- Both waysNARENDER MOHAN GUPTABought 65,600 at ₹104.42Sold 1,600 at ₹106.60Net +64,000 shares₹0.68 Cr bought
- SoldJOSEPH ANTONYSold 44,800 at ₹107.38₹0.48 Cr
- Both waysK S SHAHBought 8,000 at ₹103.85Sold 49,600 at ₹104.55Net −41,600 shares₹0.08 Cr bought
- Both waysJAYNEEL SECURITIES PRIVATE LIMITEDBought 44,800 at ₹107.25Sold 44,800 at ₹107.61Net nil₹0.48 Cr bought
Thursday 12 Oct 201718 firms · ₹12 Cr bought · ₹9.43 Cr soldNet bought ₹2.88 Cr
- Both waysVALUEWORTH CAPITAL MANAGEMENT PVT LTDBought 2,99,200 at ₹102.00Sold 1,44,000 at ₹102.00Net +1,55,200 shares₹3.05 Cr bought
- SoldEDELCAP SECURITIES LIMITEDSold 65,600 at ₹101.97₹0.67 Cr
- SoldSUMAN P SABOOSold 64,000 at ₹102.00₹0.65 Cr
- SoldBASANT KUMAR KEDIA HUFSold 62,400 at ₹101.95₹0.64 Cr
- SoldPRAHLADRAI SAGARMAL SABOOSold 62,400 at ₹96.96₹0.61 Cr
- SoldKINNARI J. KHANDWALASold 59,200 at ₹102.00₹0.60 Cr
- BoughtUSHA DINESH SHAHBought 51,200 at ₹102.00₹0.52 Cr
- BoughtV N SHAHBought 51,200 at ₹102.00₹0.52 Cr
- Both waysGARNET INTERNATIONAL LIMITEDBought 1,45,600 at ₹101.94Sold 94,400 at ₹102.00Net +51,200 shares₹1.48 Cr bought
- BoughtK S SHAHBought 49,600 at ₹102.00₹0.51 Cr
- BoughtP P VORABought 49,600 at ₹102.00₹0.51 Cr
- BoughtSHATRUNJAY INVESTMENTSBought 49,600 at ₹102.00₹0.51 Cr
- BoughtVISHAL BHANDARIBought 48,000 at ₹101.38₹0.49 Cr
- Both waysJOSEPH ANTONYBought 1,28,000 at ₹101.99Sold 83,200 at ₹102.00Net +44,800 shares₹1.31 Cr bought
- BoughtVARSHNEY ALPNABought 44,800 at ₹101.83₹0.46 Cr
- Both waysRAHUL DOSHIBought 78,400 at ₹100.61Sold 78,400 at ₹102.00Net nil₹0.79 Cr bought
- Both waysSUNITA MEHTABought 1,39,200 at ₹101.67Sold 1,39,200 at ₹101.94Net nil₹1.42 Cr bought
- Both waysCHANDARANA INTERMEDIARIES BROKERS P. LTDBought 75,200 at ₹100.90Sold 75,200 at ₹101.20Net nil₹0.76 Cr bought
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 42 deals on record since listing on 12 Oct 2017.